The increasing numeral of genome projects globally, tied with dipping genetic analysis costs; amplified research, investments, technological advancement in the life science industry, and growing incidence of genetic disorders; are the fuels for the escalation of the market.
But, restricted reimbursements for genetic testing are expected to restrain the expansion of this market.
Increase in the funds & grants from the government, advancement in the genomic technological facade, investments in research & development have vast opportunities for this market.
The polymerase chain reaction (PCR), the academic & research institutes from the Application segment, End-user segment respectively, dominated the biggest share of the Molecular Biology Enzymes & Kits & Reagents Market
The growth in the Asia Pacific is due to the increase in the funding from government, increasing research activity, the increasing bio-clusters and bio-tech parks.
North America owns the major share of this market; this is due to the increase in funding of translational and clinical research, increasing the figure of pharmaceutical and biotechnology companies, rising investments in research projects in Canada favourable reimbursement scenario.
The global Molecular Biology Enzymes & Kits & Reagents Market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; ADS Biotec Inc., Agilent, Aldevron, Bio Basic, Bio-Rad Laboratories, Inc.¸Genekam Biotechnology, Goldsite Diagnostics Inc., Hangzhou Matridx Biotechnology Co. Ltd., Illumina, Integrated DNA Technologies, Inc., Jena Bioscience, LGC Biosearch Technologies, Lucigen Corporation, Merck,MoBiTec GmbH, Molecular Biology Resources, New England Biolabs, NZYTech, Promega, QIAGEN, Randox, Roche, Takara Bio, Thermo Fisher, Zymo Research Corporation.
SPER Market Research study aims to provide market dynamics, demand and supply with yearly forecast to 2030. This report provides data for growth estimates and forecasts for Product segment- Kits & Reagents, Enzymes, Polymerases, Ligases, Restriction Endonucleases, Reverse Transcriptases, Other Enzymes, for Application segment- PCR, Sequencing, Cloning, Epigenetics, Restriction Digestion, Synthetic Biology, Other Applications, for End-User segment- Academic & Research Institutes, Pharmaceutical & Biotechnology companies, Hospitals & Diagnostic Centers, Other End Users.
This report also provides the data for key regional segments of North America, Europe, Asia-Pacific and Rest of the World.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.